News
Zacks Investment Research on MSN17h
Pharma Stock Roundup: BAYRY Q1 Earnings, NVO & GSK's New DealsBayer BAYRY announced first-quarter 2025 results. Novo Nordisk NVO and GSK plc GSK announced licensing deals with smaller ...
Novo Nordisk announced it will work with the biotech Septerna to develop oral GLP-1 obesity drugs in a deal worth up to $2.2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback